Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 41,500 shares at $45.00 ($1.9M) on 2016-07-28, disclosed to the SEC on 2016-07-29.
Scheduled sale ($1.9M) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 34,500 | $1.6M | 83.1% |
| 2 | $45.02 | 7,000 | $315K | 16.9% |
| Total | $45.00 avg | 41,500 | $1.9M | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |